ACE and acute kidney injury: No significant differences were found between angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, and the higher AKI risk observed with nonselective COX inhibitors compared with COX-2-selective agents disappeared after adjustment for time-dependent covariates.